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Abstract.  Hepatocyte growth factor (HGF) is a 
mesenchymal  derived growth factor known to induce 
proliferation  and "scattering"  of epithelial  and en- 
dothelial  ceils.  Its receptor is the tyrosine kinase en- 
coded by the c-MET protooncogene.  Here we show 
that highly purified recombinant  HGF stimulates 
hemopoietic progenitors to form colonies in vitro.  In 
the presence of erythropoietin,  picomolar concentra- 
tions of HGF induced the formation  of erythroid 
burst-forming  unit colonies from CD34-positive cells 
purified from human bone marrow,  peripheral  blood, 
or umbilical cord blood.  The growth stimulatory  ac- 
tivity was restricted to the erythroid lineage.  HGF 
also stimulated the formation of multipotent  CFU- 
GEMM colonies.  This effect is synergized by stem cell 
factor,  the ligand  of the tyrosine kinase  receptor en- 
coded by the c-KIT protooncogene,  which is active on 
early hemopoietic progenitors.  By flow cytometry 
analysis,  the receptor for HGF was found to be ex- 
pressed on the cell surface in a  fraction of CD34 ÷ pro- 
genitors.  Moreover,  in situ hybridization  experiments 
showed that HGF receptor mRNA is highly  expressed 
in embryonic erythroid cells (megaloblasts).  HGF 
mRNA was also found to be produced in the em- 
bryonal liver.  These data  show that HGF plays a  direct 
role in the control of proliferation  and differentiation 
of erythroid progenitors,  and they suggest that it may 
be one of the long-sought mediators  of paracrine  inter- 
actions between stromal and hemopoietic cells within 
the hemopoietic microenvironment. 
H 
~PATOCVa'E growth  factor  (HGF) 1 (Nakamura  et 
al.,  1989;  Miyazawa et al.,  1989),  also known as 
scatter factor (Naldini et al.,  1991a; Wiedner et al., 
1991),  has the unique feature of combining mitogenic and 
motogenic activities on its target cells. HGF is mitogenic for 
hepatocytes  (Michalopoulos,  1990)  and  other  epithelial 
cells, such as kidney tubular epithelium,  melanocytes, and 
keratinocytes (Kan et al.,  1991; Rubin et al.,  1991; Halaban 
et al.,  1992; Matsumoto et al.,  1991).  In these cells, HGF 
also promotes "scattering" (Stoker et al.,  1987; Gherardi et 
al., 1989; Weidner et al., 1990, 1991; Naldini et al., 1991a) 
and matrix  invasion (Weidner et al.,  1990;  Naldini et al., 
1991a), and it has chemotactic properties (Morimoto et al., 
1991; Giordano et al., 1993). The factor stimulates extracel- 
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1. Abbreviations  used in this paper: BFU-E, burst-forming unit-erythroid; 
CFU-GEMM,  colony-forming  unit-granulocyte,  erythroid,  monocyte, 
megakaryocyte;  CFU-GM,  colony-forming  unit-granulocyte,  monocyte; 
CFU-mng, colony-forming unit-megakaryocyte; dpc, days postcoitum; GM- 
CSE granulocyte-macrophage colony-stimulating factor; HGF, hepatocyte 
growth  factor;  IMDM,  Iscove  modified  Dulbecco's  medium;  MNAC, 
mononuclear  nonadherent cells;  SCE stem cell factor. 
lular matrix degradation by enhancing  the synthesis of en- 
zymes involved in extracellular matrix proteolysis (Pepper et 
al., 1992; Boccaccio et al., 1994). HGF acts as a morphogen 
during neuroectodermal development in vivo (Stem et al., 
1990), and it induces three-dimensional organization of epi- 
thelial cells in vitro (Montesano et al., 1991). The factor also 
promotes the progression of carcinoma cells toward malig- 
nant invasive phenotypes (Weidner et al.,  1990). 
The HGF molecule shares several structural  similarities 
with plasminogen and other proteins of the blood coagula- 
tion cascade.  These similarities  include four characteristic 
"kringle" domains at the amino terminus, a zymogen activa- 
tion site, and a carboxy-terminal serine protease-like domain 
(Miyazawa et al.,  1989;  Nakamura  et al.,  1989;  Sottrup- 
Jensen et al., 1978). HGF is secreted by cells of mesodermal 
origin  as  an  inactive  single  chain  precursor  (pro-HGF), 
which is converted to the active form in the extracellular en- 
vironment by urokinase and/or a thrombin-activated serum 
protease  (Naldini  et  al.,  1992;  Miyazawa  et  al.,  1993; 
Shimomura et al.,  1993). Mature HGF is a disulfide-linked 
heterodimer  of a  60-kD  t~  chain  and  a  32-kD  /~  chain 
(Nakamura et al.,  1989; Gohda et al.,  1988). 
The receptor for HGF is the tyrosine kinase encoded by 
the METprotooncogene (Naldini et al.,  1991a, 1991b; Bot- 
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50-kD a  subunit, disulfide-linked to a transmembrane  145- 
kD ~/subunit (Park et al.,  1987;  Giordano et al.,  1989a). 
Both  subunits  derive  from  glycosylation  and  proteolytic 
cleavage of a 170-kD single chain precursor (Giordano et al., 
1989b). 
HGF binding triggers autophosphorylation of two tyrosine 
residues  (y1234_yI235) located in the catalytic domain of the 
receptor,  upregulating  its  kinase  activity  (Naldini  et  al., 
1991a; Ferracini et al., 1991; Longati et al., 1994). Negative 
regulation occurs through phosphorylation of a unique ser- 
ine  residue  (S  9s5) in  the juxtamembrane  domain  of the ~/ 
chain (Gandino et al.,  1990,  1991,  1994). 
Signaling  by the  HGF receptor  involves multiple  path- 
ways,  as  expected  from  the  pleiotropic  response  that  its 
ligand elicits in target cells (Bardelli et al.,  1992; Graziani 
et al.,  1991,  1993; Ponzetto et al.,  1993). As in other tyro- 
sine kinase receptors, signal transduction is mediated by the 
interaction  ("docking")  between specific phosphotyrosines 
and cytoplasmic effectors containing SH2 domains (Koch et 
al.,  1991;  Pawson and Schlessinger,  1993;  Cantley et al., 
1991).  We recently  showed that  the pleiotropic  action  of 
HGF is caused by ligand-induced  autophosphorylation  of 
two tyrosines in the receptor tail (y1349,  y,st) generating a 
nonconventional docking site capable of activating multiple 
cytoplasmic signal transducers  (Ponzetto et al.,  1994). 
The HGF receptor is expressed in adult epithelial tissues, 
including liver, intestine and kidney (Prat et al.,  1991a;  Di 
Renzo et al.,  1991). It has been reported to be expressed in 
early stages of development of epithelial organs (Sonnenberg 
et al.,  1993), and it is often overexpressed in epithelial can- 
cer (Prat et al.,  1991a;  Di Renzo et al.,  1991).  We have 
shown that the receptor is also expressed in endothelial cells, 
and that HGF is a potent angiogenic factor both in vitro and 
in vivo (Bussolino et al.,  1992; Grant et al.,  1993). We re- 
cently cloned the promoter region of the HGF receptor gene 
(c-MET). Interestingly,  a GATA-1 consensus sequence was 
found within 300 bp upstream from the transcription  start 
site (Gambarotta et al.,  1994). The GATA motif is known 
to identify genes preferentially expressed during  erythroid 
differentiation (Martin et al.,  1989). This finding prompted 
us  to  investigate  the  expression  of the  HGF  receptor  in 
hemopoietic cell lineages and the possible role of HGF in hu- 
man hemopoiesis. 
Hemopoietic cell lineages derive from pluripotent progen- 
itors through committed precursors, characterized by the ex- 
pression of receptors  for specific factors.  Recently,  it has 
been suggested that some growth factors of nonhemopoietic 
origin may be involved in controlling proliferation and self- 
renewal  of early  and  committed  hemopoietic  precursors 
(Correa and Axelrad, 1991). In this work, we show that HGF 
selectively stimulates growth and differentiation of multipo- 
tent and erythroid progenitors. 
Materials and Methods 
Recombinant HGF 
Pull-length HGF eDNA was cloned from human liver mRNA (Naldini 
et al.,  1991a),  and it was inserted as a  BamHI-EcoRI fragment into the 
baculovirus transfer vector PVL1393  (Invitrogen, San Diego, CA). The 
recombinant vector was cotransfected with the BsuI-digested  BacPak6 viral 
DNA (Clontech Laboratories, Palo Alto, CA) into Spodoptera frugiperda 
insect cells (Sf9) by the lipofectin procedure. Positive viral clones isolated 
by dot-blot hybridization, and plaque assays were used for large-scale infec- 
tion. HGF was obtained from culture supernatant of SD-infected cells 72 h 
after infection, by affinity chromatography on a heparin-Sepharose FPLC 
column (Bio Pad Laboratories, Hercules, CA) eluted with a  linear 0.5- 
1.8 M NaCI gradient. The unprocessed recombinant factor (pro-HGF) was 
detected by Coomassie blue staining as a band of  90 kD in SDS-PAGE. Pro- 
tein concentration was estimated by Coomassie blue staining and compari- 
son with a standard curve obtained with increasing amounts of bovine se- 
rum albumin. 
HGF Labeling and Immunoprecipitation 
Pure HGF was radiolabeled as previously described (Naldini et al., 1992). 
The radiolabeled factor was immunoprecipitated, as described elsewhere 
(Naldini et al.,  1992),  with anti-HGF monoclonal antibodies. 
Scatter Assay 
The dissociation assay on MDCK cells was performed as previously de- 
scribed (Stoker et al.,  1987; Weidner et al.,  1990).  Cells were seeded at 
low density in six-well plates and exposed to HGF in fresh medium over- 
night. The scattering effect was monitored by light microscopy. 1 U of activ- 
ity was defined as the lowest amount of factor per milliliter that clearly dis- 
sociated MDCK cells. 
Thymidine Incorporation 
Primary cultures of rat hepatocytes were prepared as described (Zarnegar 
et al., 1991) and seeded on collagen (Boehringer Mannheim Biochemicals, 
Indianapolis, IN)-coated six-well cell culture cluster (Costar Corp., Cam- 
bridge, MA) in M199 medium (Sigma Immunochemicals, St. Louis, MO) 
supplemented with 100 ng/mi insulin. Medium was changed after 4 h, and 
the cultures were used within 48 h. The factors were added at the indicated 
concentrations for 24 h, then [6-3H]thymidine (28  Ci/mmol,  1 pCi/ml) 
was added in fresh medium, and the cultures were further incubated for 
18 h. Cell growth was evaluated by [3H]thymidine incorporation into TCA- 
precipitable material. 
Recombinant Growth Factors 
Human recombinant multipotent GM-CSF and human recombinant IL-3 
were kindly supplied by Sandoz (Wien, Austria) and stored at  -70°C for 
no more than 3 mo before use. Human recombinant stem cell factor was 
provided by Amgen Biologicals (Thousand Oaks, California). 
CD34  +  Cell Separation 
Bone marrow, fetal umbilical cord blood, and adult peripheral blood sam- 
ples were obtained from volunteers after informed consent. Heparinized 
samples of bone marrow, cord blood, or peripheral blood were diluted with 
an equal volume of PBS, and were separated by Ficoll-Hypaqu¢ 1077 SD 
(Pharmacia Fine Chemicals, Piscataway,  NJ) density gradient centrifuga- 
tion at 550 g for 30 rain. Light-density mononuclear cells were collected, 
washed twice in  PBS,  and  resuspended in  Iscove modified Dulbecco's 
medium (IMDM) (Gibco BRL, Gaithersburg, MD) supplemented with 5% 
FCS (Biological Industries, Kibbutz Belt Haemek, Israel). Mononuclear 
adherent cells were then removed by a two-step incubation of 30 rain each 
in plastic flasks at 37°C. 
Mononuclear nonadherent cells (MNAC)  were incubated with neur- 
aminidase-treated sheep erythrocytes for 15 rain at 37°C, centrifuged, and 
incubated for 45 rain at 4°C. T lymphocyte-depleted  MNAC were separated 
by Ficoll-Hypaque 1077 SD (Pharmacia) density gradient centrifugation. 
T lymphocyte-depleted MNAC were then incubated for 45 rain at 4°C 
with the following antibodies: anti-CD3, anti-CD4, anti-CD8, anti-CDllc, 
anti-CDl9, anti-CD57; most of the remaining B and T lymphocytes, mono- 
cytes, and granulocytes were thus removed by incubation for 45 min at 4°C 
with  immunomagnetic beads coated with anti-mouse IgG  (M-450  Dy- 
nabeads; Dynal, Inc., Great Neck, NY), subsequently collected by a mag- 
net (MPC-1 Dynabcads; Dynal). 
A positive selection of the CD34  + cells was then performed: cells were 
incubated  with an  antibody  anti-CD34  (My-10;  Becton-Dickinson Im- 
munocytom~try Systems, Mountain View, CA) for 45 rain at 4*(2, then for 
45 rain at 4°C with immunomagnetic beads coated with anti-mouse IgG; 
a 4:1  bead/cell ratio was found to provide the best recovery. CD34  + cells 
bound to the beads were then collected by a magnet (MPC-1 Dynabeads; 
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overnight incubation at 37°C was then performed; to allow CD34  + cell 
detachment, the beads were subjected to shearing forces by repeated flush- 
ing through a Pasteur pipette. Further details about the negative/positive 
double selection procedure used have been published previously (Bagnara 
et al.,  1991). 
Cell Cultures 
The colony assay for erythroid burst-forming units (BFU-E) and for mul- 
tipotent  granuioeyte-erythroid-monocyte-megakaryocyte colony-forming 
units (CFU-GEMM) was performed according to Iscove et al. (1974).  Cord 
blood, bone marrow, or peripheral blood CD34  + cells were plated in 24- 
well cell culture clusters (Costar) at a density of 2.5  x  103 cells/well, in 
a medium containing IMDM, 30%  FCS, 2  x  10  4  M  bemin, 5  x  10  -5 
/3-mereaptoethanol and 0.9%  methylcellulose. The cells were stimulated 
with the following growth factors alone or in combination: Epo, 2 ng/ml; 
IL-3,  2  ng/ml;  granulocyte-macrophage colony-stimulating factor (GM- 
CSF), 50 ng/ml; stem cell factor (SCF), 20 ng/ml; pro-HGF, 2,  10, or 40 
ng/ml. Colonies scored positive only when they appeared dark red and con- 
tained more than four aggregates. 
The assay for the 14-d granulo-monocyte colony-forming units was per- 
formed as previously described (Iscove et al., 1971). Cord blood, bone mar- 
row,  or peripheral blood CD34  + cells were plated in 24-well celt culture 
clusters (Costar) at a density of 2.5  ×  103 cells/well in a medium contain- 
ing IMDM, 20% FCS, 0.3% Noble agar (Difco Laboratories Inc., Detroit, 
MI),  and the following growth factors alone or in combination: IL-3, 2 
ng/ml; GM-CSF, 50 ng/ml; SCF, 20 ng/ml; pro-HGE 2,  10, or 40 ng/ml. 
For the megakaryocyte colony-forming unit assay, plasma clot assay was 
performed according to Vaincbenker et al. (1979).  Cord blood, bone mar- 
row,  or peripheral blood CD34  + cells were plated in 24-well cell culture 
clusters (Costar) at a density of 2.5  ×  103 cells/weU in a medium contain- 
ing IMDM, 20 mg/ml L-asparagine (Sigma), 3.4 #g/ml CaCI2,  10% bovine 
plasma  citrated  (Gibco  BRL),  1%  detoxified BSA  (fraction  V  Chon; 
Sigma), 10% of a preselected batch of heat-inactivated, pooled human AB 
serum, and the following growth factors alone or in combination: IL-3, 2 
ng/mi; GM-CSF, 50 ng/ml; SCF, 20 ng/ml; pro-HGF, 2,  10, or 40 ng/ml. 
After 12 d of incubation, the plasma clot was fixed in situ with methanol- 
acetone 1:3 for 20 rain, washed with PBS, and air dried. Fixed plates were 
stored at -20°C until immunofluorescence staining was performed; mega- 
karyocyte colony-forming unit colonies were scored as aggregates of 3-100 
cells intensively fluorescent to monoclonal antibody CD41 (Immunotech, 
Marseille, France) directed against the IIb/IIIa glycoprotein complex. Bind- 
ing  was  shown by  fluorescein-conjugated goat  anti-mouse Ig  (Becton- 
Dickinson Irnmunocytometry Systems, Mountain View, CA). 
Flow Cytometry Analysis 
Ceils  were  stained  for  flow  cytometry  analysis  using  phycoerythrin- 
conjugated anti-CD34 (Becton-Dickinson), unconjugated monoclonal anti- 
bodies DO-24 (anti-Met; Prat et al., 1991b), and SR-1 (anti-Kit; Briddel et 
al., 1992),  kindly provided by V. Brondy (University of Washington Medi- 
cal School, Seattle, WA). Detection of unconjngated antibodies was facili- 
tated  using  fluorescein-tagged goat  anti-mouse Ig  (Becton-Dickinson). 
Each analysis included 10,000 events collected in list mode on a FACScan  ® 
flow cytometer (Becton-Dickinson) and  analyzed using FACstar  ~  Con- 
sort 30 software. The instrument was gated on the basis of forward and 90 ° 
angle scatter to eliminate debris and aggregates. For two-color analysis, 
10,000 events were acquired gating on red fluorescence. Controls included 
cells stained with the second antibody alone or with a monocional antibody 
directed against the intracellular domain of the HGF receptor (DQ13;  Prat 
et al.,  1991b). 
Mice 
C57/B16  mice were mated between 9 and 10 p.m. Day 0.5 postcoitum was 
assumed to begin on the middle of the day of vaginal plugging. Pregnant 
female mice were killed by cervical dislocation, and embryos were staged 
according to Theiler et al. (1989),  collected in ice-cold PBS under a dissec- 
tion microscope (SVI1; Carl Zeiss, Inc., Thornwood, NY), and fixed in4% 
paraformaldehyde overnight. 
In Situ Hybridization 
In situ hybridization was carried out as described (Wilkinson and Green, 
1990; Wilkinson, 1992), with minor modifications.  Both paraffin-embedded 
and cryostat sections were analyzed. Dissected embryos were prefixed in 
0.1 M sodium phosphate buffer (pH 7.3), 4 % paraformaldehyde at 4°C over- 
night, and embedded in Ttssue-Tek  TM  (Miles Laboratories Inc., Elkhart, 
IN).  8-#m thick cryosections were transferred onto gelatin/chromium HI 
potassium sulphate-subbed slides and dried at room temperature. Before 
hybridization,  slides  were  postfixed.  The  probes  used  were  antisense 
strands corresponding to nueleotides 2199-2718  for murine c-Met, as well 
as the entire coding sequence for HGE Transcription reactions with T7 or 
Sp6 polymerase (Riboprobe Kit;  Promega Biotec,  Madison,  WI)  were 
carried out  in the presence of [3sS]CTP  (Amersham Corp.,  Arlington 
Heights, IL).  The template was then degraded with RNase-free DNase 
(Pharmacia), and the labeled RNA was purified through a Sephadex G-50 
column and progressively degraded by random alkaline hydrolysis to im- 
prove access to RNA in situ. The probes were dissolved at a working con- 
centration of 1 x  103 cpm/ml in the hybridization mix; 30 ml of the appro- 
priate  probe  was  added  to  each  slide.  Hybridization  was  carried  out 
overnight at 55°C. The slides were then washed under stringent conditions 
(65°C, 2x  SSC, 50% formamide) and treated with RNase. Autoradiogra- 
phy was performed with Kodak NT/B2 emulsion. Exposure times were be- 
tween 15 and 25 d. 
Negative controls included the c-MET and the HGF sense strands, and 
probes for the homeotic genes Otx/, Otx2, Emxl, and Emx2 (Simeone et al., 
1992),  which were tested on sections adjacent to those hybridized with the 
specific  antisense  strands  to  determine  the  basal  background  of the 
hemopoietic cells. These probes never gave a detectable signal. 
Results 
Production of  Human Recombinant HGF 
in Insect Cells 
Since  purity  is  mandatory  to  assess  the  properties  of  a 
growth factor in biological assays, we produced human HGF 
in insect cells by means of a recombinant baculovirus. Insect 
cells can be grown in serum-free medium, thus the recom- 
binant protein can be recovered devoid of serum-derived, bi- 
ologically  active  contaminants.  Moreover,  because  of the 
phylogenetic distance between insects and humans, the pos- 
sible  interference  of other  contaminating  molecules  pro- 
duced by insect cells is negligible. 
The full-length human HGF eDNA (Naldini et al., 1991a) 
was inserted into the baculovirus genome by a transfer  vec- 
tor, as described in Materials and Methods. Sf9 insect cells 
infected with the recombinant virus released the human pro- 
tein  in  the  culture  medium  as  single-chain  unprocessed 
pro-HGF.  The protein was purified from spent medium by 
heparin affinity chromatography. No contaminants could be 
detected  in  SDS-PAGE  by  Coomassie  blue  staining.  The 
baculovirus pro-HGF migrated with the apparent molecular 
masses of 90 or 65 kD, under reducing or nonreducing con- 
ditions, respectively (Fig.  1 a). The observed shift is caused 
by the reduction of intrachain disulfide bonds (Gohda et al., 
1988). 
We have previously shown that also mammalian cells se- 
crete HGF in the extracellular environment as an inactive 
single-chain precursor. Pro-HGF is converted into the ma- 
ture  two-chain  biologically  active  form  upon  proteolytic 
cleavage by urokinase or a Factor XII-like serum protease 
(Naldini et al.,  1992; Miyazawa et al.,  1993; Shimomura et 
al., 1993). Since the biological assays used in this study were 
performed in the presence of serum (see above), we tested 
whether the baculovirus pro-HGF could be processed after 
incubation for 2 h with 10% FCS.  Under these conditions, 
the  ~25I-labeled precursor was  fully processed,  generating 
the two-chain mature form (Fig.  1 b). 
The  biological  activity  of the  recombinant  baculovirus 
HGF  was  assessed  in two different  biological  assays,  and 
Galimi et al. Hepatocyte Growth Factor Is a Hemopoietic Factor  1745 Figure 1. Biochemical and biological properties of human recombinant HGF, produced in the baculovirus expression system. (a) Under 
nonreducing conditions (lane 1 ), pro-HGF shows an apparent molecular mass of ~60 kD. Under reducing conditions (lane 2), the band 
shifts to a molecular mass of 90 kD. No contaminants can be detected in the preparation  by SDS-PAGE and Coomassie blue staining. 
(b) Maturation of pro-HGF. Immunoprecipitation  and SDS-PAGE analysis of 125I-labeled unprocessed pro-HGF (lane 1 ).  In vitro pro- 
cessing of pro-HGF was obtained by a 2-h incubation with fetal calf serum (10%); under these conditions, pro-HGF is cleaved, and it 
generates the 60-kD tx chain and the 32-kD/3 chain (lane 2).  (c) Mitogenic activity of HGF measured by [3H]thymidine incorporation 
assay on primary rat hepatocytes. (d) "Scatter" of  MDCK cells cultured in standard medium (top) or after an 18-h incubation with pro-HGF 
(10 ng/mi). 
titrated by comparison with HGF obtained from mammalian 
cells. The mitogenic activity was measured in a  pH]thymi- 
dine incorporation assay, using primary rat hepatocytes. The 
cell "scatter" activity (Gherardi et al.,  1989; Weidner et al., 
1990)  was evaluated on Madin-Darby canine kidney ceils 
(Fig.  1, c and d).  The recombinant molecule was active in 
both assays. It should be noted that the "scatter" assay was 
performed in the presence of 10%  serum, while the  [3H]- 
thymidine incorporation assay was performed in the absence 
of serum. However, it is known that hepatocytes can process 
pro-HGF  as  they  express  the  appropriate  convertase(s) 
(Naka et al.,  1992;  Mizuno et al.,  1992,  1994). 
HGF Stimulates Erythroid and Multipotent 
Hemopoietic Progenitors In Vitro 
The  effect of HGF  on  the  growth  and  differentiation  of 
hemopoietic progenitors was studied in colony formation as- 
says.  CD34  + hemopoietic progenitors  (Civin et al.,  1984) 
were purified from adult bone marrow, fetal umbilical cord 
blood, or adult peripheral blood, as described in Materials 
and  Methods.  The  recovered cells  were  morphologically 
unidentifiable blast elements on May-Grunwald-Giemsa stain- 
ing, slightly contaminated by promyelocytes. Flow cytome- 
try analysis indicated that the percentage of CD34  + cells in 
the selected cell preparations varied between a minimum of 
30%  (when the starting material was bone marrow) and a 
maximum of 50% (when the starting material was umbilical 
cord blood).  Contamination  by  CD4  +,  CD2  +,  CD16  ÷,  or 
CD19  + cells was constantly <1%. 
CD34+ cells were cultured in the presence of HGF alone, 
or in combination with other growth factors.  No colonies 
were observed when the factor was added alone. However, 
in the presence of standard concentrations of erythropoietin 
(2 ng/ml), HGF dramatically increased the number of colo- 
nies derived from the BFU-E precursors (Fig. 2). HGF also 
stimulated the growth of colonies derived from multipotent 
CFU-GEMM  progenitors.  The  number  of  colonies  was 
comparable to  that  obtained by combining  known hemo- 
poietic factors such as GM-CSF and IL-3 (Bot et al.,  1988; 
Gasson, 1991; McNiece et al., 1991; Miyajima et al., 1993). 
It should be noted, however, that the HGF effect was restricted 
to  the  stimulation  of CFU-GEMM  and  BFU-E.  Neither 
granulo-monocytic nor megakaryocytic colonies were ever 
observed in response to HGE 
The response to HGF was dose-dependent and could be 
observed at concentrations of HGF as low as 5 pM both in 
erythroid and multipotent colonies (Fig.  3). 
The HGF action was also studied on CD34  + fetal hemo- 
poietic progenitors  enriched  from human umbilical cords 
blood. It is known that this population contains a percentage 
of primitive stem cells higher than the population purified 
from adult bone marrow or peripheral blood (Broxmeyer et 
al.,  1992; Lu et al.,  1993). As observed in the case of adult 
hemopoietic progenitors, HGF stimulated both BFU-E- and 
CFU-GEMM-derived colonies (data not shown). 
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Figure 2.  Colony  formation  from CD34 + human  bone marrow 
progenitors  grown  in the  presence  of standard  concentration  of 
erythropoietin  (2  ng/ml)  and  various  combinations  of human 
recombinant growth factors. (a) Erythropoietin alone. (b) 5 ng/ml 
HGE (c) 50 ng/ml GM-CSF and 2 ng/ml IL-3. The data reported 
are the total colonies counted in four distinct wells (2,500 CD34 + 
cells were seeded per well). Error bars indicate standard deviation. 
BFU-E colonies were scored positive only if containing  four or 
more cell aggregates. 
HGF Synergizes with SCF in Stimulating Multipotent 
Hemopoietic Progenitors 
In the presence of both HGF and SCF, a significant increase 
in  the  number of CFU-GEMM-derived colonies was ob- 
served (Fig. 4). Interestingly, fewer erythroid colonies could 
be seen compared to those developed in the cultures stimu- 
lated by HGF alone.  This suggests that the combination of 
HGF and SCF preferentially affects proliferation of multipo- 
tent progenitors. The erythroid colonies grown in the pres- 
ence of both growth factors were extremely large, and they 
showed  a  high  hemoglobin  content.  The  size  of  CFU- 
GEMM-derived colonies grown in these conditions was also 
increased and, within each colony, the erythroid lineage was 
predominant (Fig.  5). 
In these assays, HGF did not synergize with GM-CSF and 
IL-3, either tested individually or in combination (data not 
shown). 
The HGF Receptor Is Expressed in a Subpopulation of 
Adult Hemopoietic Progenitors (CD34  +) 
The presence of HGF receptor at the surface of hemopoietic 
progenitors was studied by flow cytotnetry analysis of bone 
marrow and peripheral blood mononuclear cells. Monoclo- 
nal antibodies directed against extracellular epitopes of the 
HGF receptor ~ chain were used. A small but clearly iden- 
tifiable subpopulation of bone marrow cells stained positive 
for the HGF receptor (Table I). About half of the cells ex- 
pressing  the  HGF  receptor  also  coexpressed  the  CD34 
marker and could, thus, be identified as hemopoietic progen- 
itors (Civin et al.,  1984). 
As  described  above,  HGF  synergized with  the  SCF  in 
stimulating the growth and differentiation of CFU-GEMM- 
derived colonies. In line with this observation, a subpopula- 
tion of cells coexpressing the HGF and the SCF receptors 
was identified using a monoclonal antibody against extracel- 
lular epitopes of the SCF-R (c-Kit) protein. 
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Figure 3.  HGF-induced  colony  formation  from CD34 + human 
bone marrow progenitors. The action of HGF on the formation of 
both BFU-E and CFU-GEMM colonies is dose dependent with a 
peak at the concentration of '~5 ng/ml. All tests were performed 
in the presence of  2 ng/ml erythropoietin. The dashed line indicates 
the number of colonies obtained in the presence of erythropoietin 
alone. 
Similar results were obtained by flow cytometry analysis 
of CD34  + progenitors  circulating  in  the  peripheral blood 
(data not shown). 
Flow cytometry analysis with anti-HGF-receptor antibod- 
ies was also performed on cells harvested from the colonies 
developed in vitro in response to HGE Table I shows that 
HGF receptor-positive cells were present. 
a  b  c 
~=~  ~=~  ~=3,=, 
SCF  HGF  HGF + SCF 
Figure 4. Synergistic effect of HGF and SCF on colony formation 
from CD34 + human bone marrow progenitors grown in the pres- 
ence of standard concentration of erythropoietin. (a) 20 ng/ml SCF 
alone. (b) 5 ng/ml HGE (c) 20 ng/ml SCF  +  5 ng/ml HGE 
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HGF and  SCF in promoting 
erythroid  differentiation  un- 
der  the  conditions  described 
in the legends of Figs. 2 and 4. 
(a)  BFU-E-derived  colony 
developed  in the presence of 
HGF  (5  ng/ml).~ (b)  BFO- 
E-derived  colony  grown  in 
the  presence  of HGF  (same 
concentration)  and  SCF  (20 
ng/ml).  (c)  CFU-GEMM- 
derived colony in the presence 
of HGF  and  SCF,  as  in  b. 
Among  the  mixed  lineages, 
the  erythroid  elements  are 
predominant. Table L Expression of  HGF Receptor (HGF-R) in Human 
Hemopoietic Progenitors 
Percent of 
Phenotype  Positive Cells 
Unfractionated bone marrow  HGF-R + 
HGF-R +/CD34 + 
HGF-R+/CD34- 
HGF-R +/SCF-R + 
HGF-R+/SCF-R- 
CFU-GEMM-derived colonies  HGF-R+ 
BFU-E-derived colonies  HGF-R + 
0.6  +0.1 
0.3  5:0.05 
0.3  +  0.1 
0.2  5:0.1 
0.4  +0.1 
t5.3  5:1.5 
9.7  5:1.2 
HGF and its Receptor Are Expressed during the 
Embryonal Development of  Hemopoietic Cells 
The  expression  of the  HGF  receptor  was  studied  in em- 
bryonal hemopoietic cells by in situ hybridization of histo- 
logical sections of mouse embryos. Using an antisense MET 
probe, the HGF receptor mRNA could be clearly detected 
in megaloblastic cells located within the cavity of the de- 
veloping heart and aorta from 10 to 10.5 d postcoitum (dpc) 
(Fig. 6, a' and c). Specific mRNA could also be detected in 
the hepato/biliary primordium,  which at this stage contains 
hemopoietic precursors (Fig. 6 b'). In this developing organ, 
both epithelial cells and erythroid islands stained positive. 
Hemopoietic cells showed a higher level of HGF receptor 
mRNA, compared to the level of expression observed in the 
surrounding hepatocytes. From 11 dpc, the hemopoietic em- 
bryonal liver also expresses HGF mRNA (Fig. 7). The reso- 
lution of in situ hybridization with 35S-labeled probes does 
not allow positive assignment of hybridization signals to sin- 
gle cells (Sonnenberg et al.,  1993). However, although we 
were not able to identify the subpopulation of cells that ex- 
press the HGF mRNA in the hepato/biliary primordium, the 
presence of these elements in close proximity and within the 
islands of erythroid progenitors suggests juxtacrine interac- 
tions. 
Discussion 
Hemopoietic cell growth and differentiation is under the con- 
trol of a complex network of cytokines, which act on their 
target cells via specific receptors (Metcalf, 1984; Clark and 
Kamen, 1987). Among these receptors, some are transmem- 
brane tyrosine kinases  expressed by different hemopoietic 
lineages. The macrophage colony-stimulating factor receptor 
kinase, encoded by the c-FMS protooncogene, is involved in 
monocyte differentiation (Stanley et al., 1983; Sherr,  1990). 
The receptor for SCF, encoded by the c-k/t gene, is critical 
for early hemopoiesis and mast cell differentiation (Besmer 
et al.,  1991; Chabot et al.,  1988; Broxmeyer et al.,  1992). 
Some new members of the receptor tyrosine kinase super- 
family (FLT-1, FLT-3, FLT-4, and FLK-1  ) have recently been 
identified in hemopoietic cells (Rosnet et al.,  1991; Shibuya 
et al., 1990; Matthews et al., 1991; Aprelikova et al., 1992). 
Two transmembrane  tyrosine kinases  encoded by genes 
related  to the c-MET protooncogene are known to be in- 
volved in hemopoiesis.  (a) The v-sea oncogene, originally 
isolated from a strain of avian erythroblastosis virus, causes 
erythroblastosis  and  anemias  in  chickens  (Smith  et  al., 
1989).  (b) The recently cloned MRK (MET-related kinase) 
gene  is  expressed  in  early  erythroid  progenitors  and  in 
differentiated hemopoietic cell lineages  (Yee et al.,  1993; 
Tamagnone et al.,  1993; Stacker et al.,  1993). 
The c-MET protooncogene encodes the tyrosine kinase 
receptor for HGF (Naldini et al.,  1991a,  1991b; Bottaro et 
al.,  1991). The expression of this gene has been considered, 
so far,  mainly  restricted  to epithelial  tissues  (Prat  et al., 
1991a;  Di Renzo et al.,  1991). We recently identified in the 
c-MET promoter,  among  other  consensus  sequences  for 
transcription factors, a GATA consensus motif (Gambarotta 
et al.,  1994).  The GATA-1 transcription  factor is the first 
characterized member of a multigene family considered to 
be  of major  importance  in  the  establishment  and  main- 
tenance of the erythroid phenotype (Martin et ai.,  1989). In 
this work, we demonstrate that the HGF receptor is indeed 
expressed in the adult by hemopoietic progenitors,  as well 
as in the embryo by erythroblast ancestors (megaloblasts). 
We also show that  HGF,  traditionally  regarded  as a  non- 
hemopoietic  growth  factor,  is  a  potent  stimulator  of the 
proliferation  and  differentiation  of the  erythroid  lineage. 
This action is lineage specific because it does not affect either 
granulo-monocytic  or  megakaryocytic lineage  precursors. 
Several lines of evidence suggest that HGF action on hemo- 
poietic cells is direct.  (a) In the adult, HGF receptor is ex- 
pressed by a  fraction  of CD34  + hemopoietic  progenitors. 
(b) In the embryo,  HGF receptor mRNA is expressed by 
primordial  erythrocytes (megaloblasts),  both in peripheral 
blood and in hemopoietic liver. (c) The HGF and the SCF 
receptors are coexpressed in a subpopulation of progenitors, 
in agreement with the synergistic effect of the two ligands. 
(d) HGF stimulates only erythroid and multipotent progeni- 
tors.  Granulo-monocytic  colony  formation  would  be  ex- 
pected in the case of an HGF-induced secretion of cytokines 
(e.g.,  IL-3  or  GM-CSF;  Gasson,  1991;  Miyajima et al., 
1993).  However, the direct action of HGF on hemopoietic 
progenitors does not exclude, in principle,  a possible addi- 
tional indirect effect in vivo mediated by cells of the bone 
marrow stroma responsive to the growth factor. Notably, en- 
dothelial  cells  express  the  HGF receptor and  respond  to 
HGF (Bussolino et al.,  1992; Grant et al.,  1993). 
The  HGF  receptor  expression  in  both  endothelial  and 
erythroid cells is consistent with their common ontogenetic 
origin,  both lineages deriving  from the same ancestors in 
yolk-sac blood islands (see Gilbert, 1988). The HGF recep- 
tor mRNA has actually been found in the hemopoietic tissue 
of extra-embryonal mesoderm (Simeone et al.,  manuscript 
in preparation). 
Erythropoiesis is a complex process in which a specific 
genetic  program  is  primed  (commitment)  and  executed 
(maturation).  Although  much is known about maturation, 
most of the molecular events occurring during the commit- 
ment phase are still obscure (for a review see Takeshita and 
Benz, 1991). Growth and differentiation of erythroid precur- 
sor are regulated by humoral factors and by largely unchar- 
acterized cell-ceU interactions  with bone marrow  stroma, 
the so-called hemopoietic microenvironment (Metcalf, 1987). 
Erythropoietin has long been considered the major factor re- 
quired  for  erythropoiesis  (Koury  and  Bondurant,  1990), 
other factors being far less specific (IL-3, GM-CSF, TGF-/3; 
Gasson,  1991;  Miyajima et al.,  1993;  Sporn and Roberts, 
1992). HGF represents a novel example of a humoral factor 
specifically active on erythropoiesis. 
Galimi et al. Hepatocyte  Growth Factor Is a  Hemopoietic  Factor  1749 Figure 6. In sire analysis of c-MEF(HGF receptor gene) expression in 10.5-dpc mouse embryos.  (a) Toluidine blue-stained sagittal section 
showing the branchial arches (ba) and the heart ventricle (by) containing circulating  megaloblastic  cells (rob). (b) Toluidine blue-stained 
sagittal  section of the hepatofoiliary primordium (hb) adjacent  to the heart ventricle (by), including  nests of megaloblastic  hemopoietic 
cells (rob). (a'-b') Dark field of  the same section shown in a and b, hybridized with the c-METantisense probe. Both circulating megaloblasts 
and hemopoietic nests  in the liver express  a high level of HGF receptor mRNA. In the hepato/biliary primordium, the epithelial  cells 
are also positive.  (c) High magnification  of a sagittal  section through the embryonic aorta.  HGF receptor mRNA is expressed  only in 
the megaloblastic  cells  filling the lumen. Figure  7.  In  situ analysis of 
HGF expression in the hemo- 
poietic  liver  of  mouse  em- 
bryo.  (a)  Toluidine blue- 
stained  sagittal section of a 
13.5--dpc embryo showing the 
hepato/biliary  primordium 
(hb).  (a)  Dark  field  of the 
same section shown in a  hy- 
bridized with the  HGF anti- 
sense probe. (b) High magni- 
fication of a  sagittal section 
through the hepato/biliary pri- 
mordium  of a  12.5-dpc em- 
bryo. The darker cells corre- 
spond  to  hemopoietic  nests 
surrounding  the lumen of  blood 
vessels (lu). 
We observed a potent synergism between HGF and SCE 
In the presence of both factors, multipotent colonies were 
significantly increased, compared to colonies grown in the 
presence of HGF alone, while erythroid colonies were nota- 
bly decreased. This observation indicates that the combina- 
tion of the two factors preferentially recruits early multipo- 
tent progenitors rather than erythroid precursors. SCF is a 
known  stimulator of early hemopoietic progenitors  (Wil- 
liams and Lyman, 1992). HGF seems to affect hemopoietic 
ceils in a window of differentiation, including the transition 
from multipotent progenitors to committed erythroid pre- 
cursors. In our experimental conditions, HGF was not syner- 
gistic with known cytokines active on hemopoietic precur- 
sors, such as GM-CSF and IL-3. This observation, obtained 
in the human hemopoietic system, does not confirm a previ- 
ous report of synergism among HGF, IL-3, and GM-CSF in 
promoting the growth of uncharacterized colonies from un- 
fractionated murine bone marrow (Kmiecik et al.,  1992). 
This discrepancy may be explained by species differences. 
Alternatively, since the mouse experiments were performed 
on total bone marrow cell suspensions (including lympho- 
cytes and  monocyte-macrophages), the  HGF effect could 
have been indirect, mediated by production of hemopoietic 
cytokines by accessory ceils. 
The potent synergism between HGF and SCF gives in- 
teresting clues.  (a) The HGF and SCF  receptors are ex- 
pressed in numerous and partially overlapping sets of target 
tissues,  including epithelia, melanocytes, and hemopoietic 
ceils (Kan et al.,  1991; Rubin et al.,  1991; Halaban et al., 
1992; Matsumoto et al.,  1991; Brizzi et al.,  1991). (b) The 
HGF and SCF receptors are tyrosine kinases that transduce 
extracellular signals via complementary pathways.  The cyto- 
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tional  docking  site  that interacts  with phospholipase-C-3,, 
pp60  TM, the GRB-2/SoS complex and, less efficiently, with 
PI 3 kinase (Graziani et al., 1991; Ponzetto et al., 1994). The 
SCF receptor, on the other hand, binds very efficiently PI 3 
kinase, while the interaction with other transducers is weak 
(Lev et al., 1991; Rottapel et al., 1991). (c) The two ligands, 
HGF and SCF, are associated to the cell surface: the SCF 
precursor is a transmembrane protein (Flanagan et al., 1991; 
Huang  et  al.,  1992)  and  HGF  is  bound  to  cell  surface 
heparansulphate glycosaminoglycans (Naldini et al., 1991a). 
Both factors may thus play a role in the juxtacrine interac- 
tions, occurring in the hemopoietic microenvironment. 
HGF  is  a  paracrine  growth  factor  that governs  mesen- 
chymal-epithelial  interactions.  It is produced by nonparen- 
chymal cells of the liver, kidney, and lung, while parenchy- 
real (epithelial)  cells in these organs express high levels of 
HGF receptor (Noji et al.,  1990). A similar expression pat- 
tern is found during development of epithelial organs, where 
the factor is secreted by mesenchymal cells and the receptor 
is expressed by adjacent epithelial cells (Sonnenberg et al., 
1993). We now suggest that HGF is a paracrine mediator of 
stromal-hemopoietic cell interactions both during embryo- 
genesis and adult life. This factor may, therefore, be one of 
the long-sought molecules mediating developmental signals 
between microenvironment and hemopoietic progenitors. 
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